Key
- This grey face represents the number of people in the survey group.
- This green face represents the one person in the survey group that the medicine has helped.
Research studies have looked at how likely it is that Nebivolol will reduce risk of death in people with mild to severe heart failure.
Research suggests:
In a group of 78 patients over 70 years old, with mild to severe heart failure, Nebivolol will prevent one person from this group (on average) from dying over a period of one year.
This picture illustrates how likely it is that a person taking Nebivolol will get this benefit.
It is not possible to tell what will happen to you as an individual.
Find out more about this research at:
https://www.ncbi.nlm.nih.gov/pubmed/15642700
(Tooltip - Mean age of patients in this study was 75 years. 87% of patients were on an ACE inhibitor or Angiotensin receptor blocker.. Nebivolol dose was 10 mg/day)